LUNA INNOVATIONS INCORPORATED — Department of Defense SBIR Phase II: DHA193-004

LUNA INNOVATIONS INCORPORATED — SBIR Phase II award from Department of Defense.

Amount
$1,499,994
Agency
Department of Defense · Defense Health Program
Program / Phase
SBIR · Phase II
Topic
DHA193-004
Solicitation
19.3
NAICS
Place of performance
VA
Period
2021-06-14 → 2023-09-16

Description

Severe hemorrhage accounts for 90% of all survivable pre-hospital deaths in military combat scenarios, as there is limited access to resuscitation fluids for transfusion. Particularly in scenarios of prolonged forward field care, there is a significant need for hemorrhage control and rapid restoration of blood volume without compromising clotting behavior or gas exchange capabilities. Luna is working on the development of a modular stabilization system that will improve dry shelf-stability of multiple components that can be reconstituted for transfusion to provide the most critical functionalities of blood. In Phase I, Luna demonstrated the feasibility of this approach using several key components, and Phase II efforts will transition to the demonstration of technology efficacy in vivo.